GILEAD SCIENCES, INC. Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31)
GILEAD SCIENCES, INC. (GILD) reported Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31) of $947.20 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Notes
us-gaap:VariableInterestEntityCarryingAmountOfLiabilitiesConsolidatedVIE · last filed 2011-05-09
- GILEAD SCIENCES, INC. variable interest entity, carrying amount of liabilities, consolidated vie (deprecated 2011-01-31) for the quarter ending 2011-03-31 was $947.20M.
- GILEAD SCIENCES, INC. variable interest entity, carrying amount of liabilities, consolidated vie (deprecated 2011-01-31) for the quarter ending 2010-12-31 was -$340.50M.
- GILEAD SCIENCES, INC. variable interest entity, carrying amount of liabilities, consolidated vie (deprecated 2011-01-31) for the quarter ending 2010-09-30 was -$60.00M.
- GILEAD SCIENCES, INC. variable interest entity, carrying amount of liabilities, consolidated vie (deprecated 2011-01-31) for fiscal 2009 was $1.03B.
| Period end | Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31) 3 month | Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31) 6 month | Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31) 9 month | Variable Interest Entity, Carrying Amount of Liabilities, Consolidated VIE (Deprecated 2011-01-31) 12 month |
|---|---|---|---|---|
| 2011-03-31 | $947.20M 10-Q · filed 2011-05-09 | $606.70M derived: sum of 2 quarters · filed 2011-05-09 | $546.70M derived: sum of 3 quarters · filed 2011-05-09 | |
| 2010-12-31 | -$340.50M derived: 10-Q 12 month − 10-Q 9 month · filed 2011-05-09 | -$400.50M derived: sum of 2 quarters · filed 2011-05-09 | $759.50M 10-Q · filed 2011-05-09 | |
| 2010-09-30 | -$60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $1.10B 10-Q · filed 2010-11-08 | ||
| 2010-06-30 | $1.16B 10-Q · filed 2010-08-09 | |||
| 2009-12-31 | $1.03B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |